Logo image of BGSF

BGSF INC (BGSF) Stock Fundamental Analysis

NYSE:BGSF - New York Stock Exchange, Inc. - US05601C1053 - Common Stock - Currency: USD

3.37  +0.04 (+1.2%)

Fundamental Rating

3

Overall BGSF gets a fundamental rating of 3 out of 10. We evaluated BGSF against 82 industry peers in the Professional Services industry. While BGSF seems to be doing ok healthwise, there are quite some concerns on its profitability. BGSF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BGSF had negative earnings in the past year.
In the past year BGSF had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BGSF reported negative net income in multiple years.
Of the past 5 years BGSF 4 years had a positive operating cash flow.
BGSF Yearly Net Income VS EBIT VS OCF VS FCFBGSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

BGSF has a Return On Assets of -2.22%. This is in the lower half of the industry: BGSF underperforms 71.95% of its industry peers.
The Return On Equity of BGSF (-4.06%) is worse than 71.95% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.77%, BGSF is doing worse than 65.85% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BGSF is significantly below the industry average of 13.48%.
The last Return On Invested Capital (0.77%) for BGSF is well below the 3 year average (7.52%), which needs to be investigated, but indicates that BGSF had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.22%
ROE -4.06%
ROIC 0.77%
ROA(3y)1.7%
ROA(5y)3.14%
ROE(3y)3.07%
ROE(5y)5.95%
ROIC(3y)7.52%
ROIC(5y)7.02%
BGSF Yearly ROA, ROE, ROICBGSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

BGSF has a worse Operating Margin (0.46%) than 67.07% of its industry peers.
BGSF's Operating Margin has declined in the last couple of years.
BGSF has a Gross Margin of 34.08%. This is comparable to the rest of the industry: BGSF outperforms 48.78% of its industry peers.
In the last couple of years the Gross Margin of BGSF has remained more or less at the same level.
Industry RankSector Rank
OM 0.46%
PM (TTM) N/A
GM 34.08%
OM growth 3Y-44.52%
OM growth 5Y-33.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y1.42%
BGSF Yearly Profit, Operating, Gross MarginsBGSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BGSF is destroying value.
BGSF has more shares outstanding than it did 1 year ago.
BGSF has more shares outstanding than it did 5 years ago.
BGSF has a better debt/assets ratio than last year.
BGSF Yearly Shares OutstandingBGSF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BGSF Yearly Total Debt VS Total AssetsBGSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

BGSF has an Altman-Z score of 2.44. This is not the best score and indicates that BGSF is in the grey zone with still only limited risk for bankruptcy at the moment.
BGSF has a Altman-Z score of 2.44. This is comparable to the rest of the industry: BGSF outperforms 45.12% of its industry peers.
The Debt to FCF ratio of BGSF is 2.04, which is a good value as it means it would take BGSF, 2.04 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.04, BGSF is in the better half of the industry, outperforming 71.95% of the companies in the same industry.
BGSF has a Debt/Equity ratio of 0.52. This is a neutral value indicating BGSF is somewhat dependend on debt financing.
BGSF's Debt to Equity ratio of 0.52 is in line compared to the rest of the industry. BGSF outperforms 42.68% of its industry peers.
Even though the debt/equity ratio score it not favorable for BGSF, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.04
Altman-Z 2.44
ROIC/WACC0.08
WACC9.21%
BGSF Yearly LT Debt VS Equity VS FCFBGSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

BGSF has a Current Ratio of 1.75. This is a normal value and indicates that BGSF is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.75, BGSF is in the better half of the industry, outperforming 70.73% of the companies in the same industry.
A Quick Ratio of 1.75 indicates that BGSF should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.75, BGSF is doing good in the industry, outperforming 70.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
BGSF Yearly Current Assets VS Current LiabilitesBGSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1

3. Growth

3.1 Past

BGSF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -165.08%.
BGSF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.99%.
BGSF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.39% yearly.
EPS 1Y (TTM)-165.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-281.82%
Revenue 1Y (TTM)-12.99%
Revenue growth 3Y4.47%
Revenue growth 5Y4.39%
Sales Q2Q%-12.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y107.46%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BGSF Yearly Revenue VS EstimatesBGSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BGSF Yearly EPS VS EstimatesBGSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

BGSF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 110.13, the valuation of BGSF can be described as expensive.
Based on the Price/Forward Earnings ratio, BGSF is valued a bit more expensive than the industry average as 65.85% of the companies are valued more cheaply.
BGSF is valuated expensively when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 110.13
BGSF Price Earnings VS Forward Price EarningsBGSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

76.83% of the companies in the same industry are more expensive than BGSF, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BGSF indicates a rather cheap valuation: BGSF is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.64
EV/EBITDA 8.69
BGSF Per share dataBGSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

BGSF's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.99%, BGSF is a good candidate for dividend investing.
In the last 3 months the price of BGSF has falen by -35.56%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 2.37, BGSF pays a better dividend. On top of this BGSF pays more dividend than 97.56% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, BGSF pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.99%

5.2 History

The dividend of BGSF decreases each year by -31.61%.
BGSF has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BGSF decreased in the last 3 years.
Dividend Growth(5Y)-31.61%
Div Incr Years0
Div Non Decr Years2
BGSF Yearly Dividends per shareBGSF Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of BGSF are negative and hence is the payout ratio. BGSF will probably not be able to sustain this dividend level.
DP-49.1%
EPS Next 2YN/A
EPS Next 3YN/A
BGSF Yearly Income VS Free CF VS DividendBGSF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

BGSF INC

NYSE:BGSF (4/29/2025, 6:40:00 PM)

3.37

+0.04 (+1.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)05-07 2025-05-07
Inst Owners33.19%
Inst Owner Change0%
Ins Owners3.71%
Ins Owner Change3.16%
Market Cap37.34M
Analysts82.5
Price Target10.71 (217.8%)
Short Float %0.46%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 5.99%
Yearly Dividend0.15
Dividend Growth(5Y)-31.61%
DP-49.1%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.74%
Min EPS beat(2)-162.39%
Max EPS beat(2)-145.1%
EPS beat(4)0
Avg EPS beat(4)-141.21%
Min EPS beat(4)-185.78%
Max EPS beat(4)-71.57%
EPS beat(8)3
Avg EPS beat(8)44.17%
EPS beat(12)6
Avg EPS beat(12)38.7%
EPS beat(16)9
Avg EPS beat(16)35.52%
Revenue beat(2)0
Avg Revenue beat(2)-6.8%
Min Revenue beat(2)-6.95%
Max Revenue beat(2)-6.65%
Revenue beat(4)0
Avg Revenue beat(4)-6.58%
Min Revenue beat(4)-9.73%
Max Revenue beat(4)-3%
Revenue beat(8)0
Avg Revenue beat(8)-4.78%
Revenue beat(12)4
Avg Revenue beat(12)0.46%
Revenue beat(16)4
Avg Revenue beat(16)-9.4%
PT rev (1m)-12.5%
PT rev (3m)-12.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-71.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.61%
Revenue NY rev (1m)-3.78%
Revenue NY rev (3m)-3.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 110.13
P/S 0.14
P/FCF 1.64
P/OCF 1.53
P/B 0.45
P/tB N/A
EV/EBITDA 8.69
EPS(TTM)-0.41
EYN/A
EPS(NY)0.03
Fwd EY0.91%
FCF(TTM)2.05
FCFY60.9%
OCF(TTM)2.2
OCFY65.29%
SpS24.59
BVpS7.43
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.22%
ROE -4.06%
ROCE 1.02%
ROIC 0.77%
ROICexc 0.78%
ROICexgc 2.24%
OM 0.46%
PM (TTM) N/A
GM 34.08%
FCFM 8.34%
ROA(3y)1.7%
ROA(5y)3.14%
ROE(3y)3.07%
ROE(5y)5.95%
ROIC(3y)7.52%
ROIC(5y)7.02%
ROICexc(3y)7.53%
ROICexc(5y)7.02%
ROICexgc(3y)62.95%
ROICexgc(5y)43.05%
ROCE(3y)9.81%
ROCE(5y)9.06%
ROICexcg growth 3Y-37.04%
ROICexcg growth 5Y-30.72%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-33.33%
OM growth 3Y-44.52%
OM growth 5Y-33.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y1.42%
F-Score5
Asset Turnover1.82
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.04
Debt/EBITDA 4.71
Cap/Depr 21.11%
Cap/Sales 0.6%
Interest Coverage 0.28
Cash Conversion 269.98%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z 2.44
F-Score5
WACC9.21%
ROIC/WACC0.08
Cap/Depr(3y)64.81%
Cap/Depr(5y)64.81%
Cap/Sales(3y)1.11%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-165.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-281.82%
EPS Next Y107.46%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.99%
Revenue growth 3Y4.47%
Revenue growth 5Y4.39%
Sales Q2Q%-12.45%
Revenue Next Year1.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.28%
EBIT growth 3Y-42.04%
EBIT growth 5Y-30.19%
EBIT Next Year1257.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.83%
FCF growth 3Y87.31%
FCF growth 5Y7.66%
OCF growth 1Y19.59%
OCF growth 3Y54.12%
OCF growth 5Y6.31%